Dr. Janakiraman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Henry Ford Health System
2799 West Grand Boulevard
Detroit, MI 48202Phone+1 313-916-5002
Education & Training
Henry Ford Health/Henry Ford HospitalFellowship, Hematology and Medical Oncology, 1980 - 1983
Westland Medical CenterFellowship, Hematology, 1979 - 1980
Stanley Medical College SMCClass of 1969
Certifications & Licensure
MI State Medical License 1981 - 2027- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) Start of enrollment: 2006 Nov 01
- Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma Start of enrollment: 2008 Dec 15
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsVariability in Cytogenetic Testing for Multiple Myeloma: A Comprehensive Analysis From Across the United StatesYang Yu, Niquelle Brown Wadé, Amie E. Hwang, Ajay K. Nooka, Mark A. Fiala
JCO Oncology Practice. 2020-05-29 - 1272 citationsIDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin's LymphomaDavid G. Maloney, Antonio J. Grillo-Lopez, Christine A. White, David Bodkin, Russell J. Schilder
Blood. 1997-09-15 - 176 citationsImmunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production.Xiaohua Gao, Yong X. Xu, Nalini Janakiraman, Robert Chapman, Subhash C. Gautam
Biochemical Pharmacology. 2001-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
